Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial

BACKGROUND: There is a need for preventative asthma maintenance therapy that provides lasting bronchoprotection against allergen provocation. Fluticasone furoate (FF) is a novel inhaled once-daily corticosteroid, being investigated as monotherapy for asthma and in combination with vilanterol (VI), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Amanda, Quinn, Dean, Goldfrad, Caroline, van Hecke, Benjamin, Ayer, Jonathan, Boyce, Malcolm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483689/
https://www.ncbi.nlm.nih.gov/pubmed/22738148
http://dx.doi.org/10.1186/2045-7022-2-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483689/
https://www.ncbi.nlm.nih.gov/pubmed/22738148
http://dx.doi.org/10.1186/2045-7022-2-11

Ejemplares similares